PCCA Science - Our Goal

is to provide the most effective, innovative, and functional products for the compounding industry. In that spirit, we have committed significant resources to the study and validation of our technology. We accomplish this by applying basic science to our research, with the goals of improving therapeutic options and advancing the profession through the publication of scholarly articles. Behind every study and product, there is a team of PhD-level scientists, chemists, and pharmacists dedicated in their pursuit of unsurpassed product innovation.

denotes an impact-factor scientific journal.

denotes a publication authored by PCCA.

Lipoderm

PracaSil-Plus

Equipment

Flavors

Dentistry

HRT

Otolaryngology

Pain Management

Scar Management

Urology

Business

Calculations

Flavoring

Marketing

Pharmacognosy

Regulatory

Stability

Technology

denotes an impact-factor scientific journal.

denotes a publication authored by PCCA.

Lipoderm

Xematop

FIP

INTERNATIONAL PHARMACEUTICAL FEDERATION

79th FIP World Congress of Pharmacy and Pharmaceutical Sciences: Abu Dhabi, United Arab Emirates 22nd-26th September, 2019

  • Pharmaceutical compounding: An alternative treatment option in Psoriasis
FIP 2019

SID

SOCIETY FOR INVESTIGATIVE DERMATOLOGY

77th Annual Meeting: Chicago (USA) 8th-11th May, 2019

  • In Vitro Evaluation of Naltrexone HCl 1% Topical Cream in Xematop for Psoriasis
EuPFI UK 1 EuPFI UK 2

EUPFI

European Paediatric Formulation Initiative

10th EuPFI Conference: London (United Kingdom) 12th-13th September, 2018

  • Physicochemical stability of omeprazole 2 mg/mL and 10 mg/mL oral suspensions in SuspendIt®
  • Physicochemical stability of lansoprazole 3 mg/mL and 10 mg/mL oral suspensions in SuspendIt®
EuPFI UK 1 EuPFI UK 2 EuPFI UK 3

BSAVA

British Small Animal Veterinary Association

BSAVA Congress 2018: Birmingham (UK) 5th-8th April, 2018

  • The use of Lipoderm as a transdermal base in veterinary compounding: A systematic literature review
BSAVA 1 BSAVA 2

APHA

American Pharmacists Association

2018 APhA Annual Meeting & Exposition: Nashville (USA) 16th-19th March, 2018

  • Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt™
APHA

EUPFI

European Paediatric Formulation Initiative

9th EuPFI Conference: Warsaw (Poland) 20th-21st September, 2017

  • Case Report of a Skin Viral Infection Treated with a Topical Extemporaneous Preparation
  • Physical and Chemical Stability of Phenobarbital 1mg/mL and 50 mg/mL Oral Suspensions (SuspendIt™)
EuPFI Poland 1 EuPFI Poland 2 EuPFI Poland 3

AAPS

American Association of Pharmaceutical Scientists

2015 AAPS Annual Meeting and Exposition: Orlando (USA) October, 2015

  • Evaluation of the Mucosal Retention Properties of Mucoadhesive Polymers Using a 3D Model of the Human Oral Mucosa

PAINWeek®

9th Annual Meeting: Las Vegas (USA) 10th-11th September, 2015

  • Evaluation of the In Vitro Percutaneous Absorption of Ketoprofen Transdermal Formulations

CPhA

California Pharmacists Association

2015 West Coast Pharmacy Exchange: Anaheim (USA) 10th-11th April, 2015

  • Case Report: Treatment of Diabetic Ulceration with Compounded Medicines
CPhA 1 CPhA 2

PBP

Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

9th PBP World Meeting: Lisbon (Portugal) 3rd April, 2014

  • Characterization of the physical and microbiological properties of a powder excipient base (Loxasperse)
  • Dissolution of Piroxicam in Capsule Formulations studied with USP and Real-Time UV Imaging Methods
PBP 1 PBP 2

FIP

INTERNATIONAL PHARMACEUTICAL FEDERATION

74th FIP World Congress: Dublin (Ireland) 31st August – 5th September, 2013

  • Compounding for Complex Patients: Pediatrics
FIP 1

Anhydrous Lipoderm

LoxaSperse

LoxOral

MucoLox

PermE8 Anhydrous Gel

PracaSil-Plus

RheoSpray

SuspendIt

VersaBase Anhydrous HRT

W06 Anhydrous Topical Gel

XemaTop

XyliFos

denotes an impact-factor scientific journal.

denotes a publication authored by PCCA.

Atrevis

Lipoderm

LoxaSperse

MucoLox

PracaSil-Plus

Sorbitol Lollipop

Spira-Wash

Vanishing Cream Light

Versabase

XemaTop

 
European Paediatric Formulation Initiative

PCCA is the exclusive sponsor of the best poster and oral presentations at the EuPFI annual scientific conference

11th EuPFI Conference: Malmö, Sweden September 10-12, 2019

  • Understanding acceptance and swallowability of bitter tasting tablets in children
  • Taste evaluation of three different commercial tablets for paediatric patients for neglected tropical diseases
  • A toolbox for simulating gastrointestinal conditions in children: Standardised dissolution media for simulating typical children's breakfasts around the world
EuPFI UK 1 EuPFI UK 2

10th EuPFI Conference: London (United Kingdom) 12th-13th September, 2018

  • Dissolution behavior of 3D printed lidocaine formulations onto mucoadhesive buccal films conventionally produced for pediatric use
  • Novel approach to disintegration testing of orodispersible films: In vitro oral cavity simulator
  • Migraine treatment using TRNA approach for teenager patient using vesicular gel
  • Best Oral Presentation: Antibiotics acceptability: contrasting effects of aromas on girls and boys
EuPFI UK 1 EuPFI UK 2 EuPFI UK 3 EuPFI UK 4

9th EuPFI Conference: Warsaw (Poland) 20th-21st September, 2017

  • Enhanced oromucosal permeation of midazolam hydrochloride released from mucoadhesive buccal films using methylated β-cyclodextrins
  • Dissolution and compatibility of hydrocortisone granules following exposure to common paediatric administration fluids and food matrices
  • Manipulation of hydrocortisone tablets: Do parents follow the advice from healthcare practitioners?
  • Best Oral Presentation: Extrusion of highly drug-loaded wax-extrudates for paediatric use
EuPFI Poland 1 EuPFI Poland 2 EuPFI Poland 3 EuPFI Poland 4 EuPFI Poland 5 EuPFI Poland 6

8th EuPFI Conference: Lisbon (Portugal) 21st-22nd September, 2016

  • A Novel Approach to Assess and Improve Palatability of an Inhaled Asset Using the Rat Brief Access Taste Aversion Assay and an In Silico Model of Salivary Flow
  • Simulating Different Dosing Scenarios for a Paediatric Valproic Acid ER Formulation in a New Paediatric Multistage Dissolution Model
  • Development and Evaluation of Taste-Masked Pediatric Minitablet Formulations with Bitter Model Drugs
  • Best Oral Presentation: Palatability and Acceptability of Multiparticulate Formulations: Adults vs. Children Comparison
EuPFI Portugal 1 EuPFI Portugal 2 EuPFI Portugal 3 EuPFI Portugal 4 EuPFI Portugal 5 EuPFI Portugal 6 EuPFI Portugal 6

7th EuPFI Conference: Antwerp (Belgium) 16th-17th September, 2015

  • Thin Substrates Manufactured by the Means of 3D-Printing-Tailor-Made Drug Delivery Systems for Paediatric Use
  • Preliminary Development of a Tool Assessing the Acceptability of Medicines for Paediatric Use
  • Can Solubilizing Excipients be Used with the Rat BATA Model to Assess the Taste of Poorly Water-Soluble Drugs?
EuPFI Belgium 1

6th EuPFI Conference: Athens (Greece) 17th-18th September, 2014

  • Development and Characterization of Dispersible Tablets Employing Novel Characterization Methods
  • Assessing the Taste of Medicines with Rodents: the In Vivo Rat Brief-Access Taste Aversion (BATA) Model
  • Monitoring Food and Fluid Intake as a Basis for Establishing Biorelevant Dissolution Methods for Children in the Age of 1 - 6 Years
EuPFI Greece 1 EuPFI Greece 2 EuPFI Greece 3 EuPFI Greece 4 EuPFI Greece 5 EuPFI Greece 6

5th EuPFI Conference: Barcelona (Spain) 18th-19th September, 2013

  • Immediate-Release Carbamazepine Formulations for Individual Dosing by the Solid Dosage Pen
  • Development of Buccal Films as Novel Dosage Form for Paediatric Use
  • End-User Perceptions of Solid Oral Dosage Forms in the UK and Canada Part 1: School Children and Adolescents
EuPFI Spain 1 EuPFI Spain 2 EuPFI Spain 3 EuPFI Spain 4

FIP

International Pharmaceutical Federation

PCCA was the exclusive sponsor of the compounding session: The Role of Compounding in Closing Therapeutic Gaps. This 6-hour session included expert speakers from the USA, Portugal, Germany and Spain, who brought together the various compounding specialties, considerations, guidelines and standards.

73rd FIP World Congress: Dublin (Ireland) 31st August – 5th September, 2013

FIP 1 FIP 2 FIP 3 FIP 4 FIP 5 FIP 6 FIP 7 FIP 8 FIP 9

IPSF

International Pharmaceutical Students’ Federation

PCCA has established a partnership with the IPSF as the official sponsor of the compounding events at the World Congress and Regional Symposia. The IPSF acknowledges the importance and necessity of compounding skills within the pharmacy profession and has created this grant, with the support of PCCA, to allow students around the world the chance to organize their own compounding events.

2018

PCCA was the proud sponsor of the following compounding events:

  • 64th IPSF World Congress: Argentina
    IPSF Argentina 1 IPSF Argentina 2

PCCA was acknowledged in the IPSF Press Release. Read here

FIP 1

2017

PCCA was the proud sponsor of the following compounding events:

  • 6th IPSF African Pharmaceutical Symposium (AfPS): Ghana
    IPSF Ghana
  • 63rd IPSF World Congress: Taiwan
    IPSF Taiwan 1 IPSF Taiwan 2
  • 16th Asia Pacific Pharmaceutical Symposium (APPS): Thailand
    IPSF Taiwan 1 IPSF Taiwan 2 IPSF Taiwan 3 IPSF Taiwan 4

PCCA was also the proud sponsor of the IPSF Development Fund Compounding Event (CE) Grants, which were attributed to:

  • Association Tunisienne des Etudiants en Pharmacie (ATEP)
  • Malaysian Pharmacy Students' Association (MyPSA)
  • Zimbabwe Pharmaceutical Students Association (ZPSA)
  • Makerere University Pharmacy Students Association (MUPSA)

PCCA was acknowledged in the IPSF Press Release

PCCA was acknowledged in the IPSF Newsletter 108

2016

PCCA was the proud sponsor of the following compounding events:

  • 5th IPSF African Pharmaceutical Symposium (AfPS): Kenya
  • 62nd IPSF World Congress: Zimbabwe

PCCA was acknowledged in the IPSF Press Release

PCCA was acknowledged in the IPSF Newsletter 107